Company / Financials
GeneDx Holdings Corp. Financials
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$427.5M
FY2025 · +40.0% YoY
Net Income
-$21.0M
FY2025 · +59.8% YoY
Profit Margin
-4.9%
FY2025 · net income / revenue
ROE
-6.8%
FY2025 · return on equity
Total Assets
$523.7M
FY2025
Total Debt
$54.5M
0.18x debt/equity
Equity
$308.2M
FY2025
ROA
-4.0%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$427.5M+40.0% YoYNet Income HistoryProfit after all expenses and taxes-$21.0M+59.8% YoYGross Profit HistoryRevenue minus cost of goods sold$298.2M+53.4% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$129.4M+16.5% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$13.1M+43.7% YoYSG&A Expense HistorySelling, general, and administrative expenses$150.8M+44.3% YoYR&D Expense HistoryResearch and development spending$72.0M+57.5% YoYInterest Expense HistoryCost of borrowing and debt obligations$3.2MIncome Tax HistoryTotal income tax expense-$116.0K+66.2% YoYEPS (Basic) HistoryBasic earnings per share-$7.230.0% YoY